Loading...
Loading...
Below are the top diagnostic substances stocks on the NASDAQ in terms of return on investment.
The trailing-twelve-month return on investment at
Nymox Pharmaceutical Corporation NYMX is 73.80%. Nymox Pharmaceutical's revenue for the same period is $3.20 million.
The trailing-twelve-month return on investment at
Meridian Bioscience, Inc.VIVO is 21.70%. Meridian Bioscience's EPS for the same period is $0.83.
The trailing-twelve-month return on investment at
IDEXX Laboratories, Inc.IDXX is 20.20%. IDEXX Laboratories' profit margin for the same period is 13.40%.
The trailing-twelve-month return on investment at
SurModics, Inc.SRDX is 11.20%. SurModics' PEG ratio is 1.66.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We simplify the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in